Last reviewed · How we verify
NCT04050020
Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function
Phase 2, PHASE3 trial testing Platelet-Rich Plasma (PRP) in Erectile Dysfunction Due to Arterial Insufficiency in 60 participants. Completed in 24 September 2020.
26 March 2020
Quick facts
| Lead sponsor | Institute for the Study of Urological Diseases, Greece |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 2 September 2019 |
| Primary completion | 26 March 2020 |
| Estimated completion | 24 September 2020 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Platelet-Rich Plasma (PRP)
- Normal saline injection
Conditions studied
- Erectile Dysfunction Due to Arterial Insufficiency — all drugs for Erectile Dysfunction Due to Arterial Insufficiency →
Sponsor
Institute for the Study of Urological Diseases, Greece
Who can join
Adults 40 to 70, male only, with Erectile Dysfunction Due to Arterial Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of the present study is to investigate and compare the treatment efficacy of PRP injection vs placebo treatment in men with mild-moderate vasculogenic ED, as measured by IIEF.The secondary objective of the present clinical trial is to study the adverse events and safety of the PRP injection treatment in vasculogenic ED patients
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Well-Forgotten Old: Platelet-Rich Plasma in Modern Anti-Aging Therapy.
Gorodilova AV, Kharisova CB, Osinnikova MN, Kitaeva KV, et al · · 2024 · cited 5× · PMID 39513862 · DOI 10.3390/cells13211755
Verify or expand the search:
- PubMed search for NCT04050020
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Platelet-Rich Plasma (PRP)
Trials testing the same drug.
- NCT07112898 — Effect of Platelet-Rich Plasma on Graft Uptake and Postoperative Outcomes in Full-Thickness Skin Grafting of Face and Ne · NA · enrolling by invitation
- NCT07408895 — Effect of Injectable Platelet Rich Derivatives on Orthodontic Canine Retraction · NA · completed
- NCT07320170 — Comparative Effects of CGF and PRP in Impacted Third Molar Surgery · NA · completed
- NCT07246434 — Platelet-Rich Plasma Versus Home-Based Exercise for Partial-Thickness Supraspinatus Tears · NA · completed
Other recruiting trials for Erectile Dysfunction Due to Arterial Insufficiency
Currently open trials in the same condition.
- NCT04434352 — Low Intensity Shockwave Therapy for Erectile Dysfunction · NA · active not recruiting
Other Institute for the Study of Urological Diseases, Greece trials
Trials by the same sponsor.
- NCT04549389 — The Ideal LiST Session Frequency Protocol for CPPS Treatment · NA · completed
- NCT03641846 — Low-intensity Shockwave Therapy (LiST) for the Treatment of Mild and Mild-to-moderate Vasculogenic Erectile Dysfunction · NA · completed
- NCT03543761 — Low-intensity Shockwave Therapy for Non-bacterial Prostatitis/Pelvic Pain Syndrome · NA · completed
- NCT03112499 — The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury · NA · completed
- NCT03518983 — Low-intensity Shockwaves Therapy for the Treatment of Patients With Moderate Vasculogenic Erectile Dysfunction · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04050020 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute for the Study of Urological Diseases, Greece
- Last refreshed: 20 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04050020.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing